Oncode Institute - Our stories

Fundamental research for tomorrow’s patients

Cancer is still a massive problem. Nowadays it is the leading cause of death in The Netherlands and 1 out of 3 people is affected by it. Why haven’t we defeated cancer yet?

ElizeBrolsma

How fundamental oncology will shape future cancer treatment

Two researchers, Jeanine Roodhart and Henk Verhuel, try to predict which fundamental research paths are most likely to improve the life of cancer patients in the future

Hidde Boersma

Oncode Institute is at full strength with 19 new cancer researchers

We are pleased to announce that 19 excellent scientists and their research groups join Oncode Institute per 2019. Oncode grows to 62 research groups, spread over 12 academic institutions throughout The Netherlands.

TaleSliedrecht

Highlights of the Oncode-CGC Annual Scientific meeting

On 10 and 11 January, Oncode and CGC researchers met at the Compagnie Theater in Amsterdam to enjoy, discuss and experience science. Apart from inspiring talks, the two-day event also offered other engaging ways to stimulate interaction.

ElizeBrolsma

The Oncode Community Platform: Connecting researchers to create impact

Oncode Institute is a mission-driven research effort that goes beyond the competitive model of science. Within Oncode, researchers are strongly encouraged to work together because we need all available talent to outsmart cancer and impact patient’s lives. Oncode has co-created a digital tool with the research community that should help researchers find the expertise they need.

MariaHayat

Oncode Institute expands by recruiting seven talented female junior investigators

We are pleased to announce that we are expanding. Seven talented female scientists have been selected to join Oncode as junior investigators.

TaleSliedrecht

Annual Conference – young researchers are the future

On November 8th and 9th 2018, cancer researchers from all over The Netherlands gathered for the Oncode-CGC Annual Conference. A quick look at the audience showed that not only the speakers were a dynamic mix of people. It is safe to say that the cancer research community is young, diverse and very motivated to create impact.

ElizeBrolsma

Medications specifically for Children with Cancer

Separate research is needed in the case of children with cancer. Children differ from adults in the types of cancer they develop. Researchers at the recently opened Princess Máxima Centre for Pediatric Oncology are looking for medications that work more specific than chemotherapy. NEMO Kennislink visited them.

OncodeEvents

First Start-up Oncode Institute launched

Oncode Investigator, Alexander van Oudenaarden, is one of the pioneers in the field of single-cell sequencing. From his lab at the Hubrecht Institute the company Single Cell Discoveries was recently launched with the help of the valorization team of Oncode.

Hidde Boersma

Fundamental Science: an uncertain endeavour into uncharted territory

Oncode invests in curiosity driven research. We asked Oncode Investigator Madelon Maurice and General Director Ton Rijnders to explain why.

Hidde Boersma

On hair balls, ink pads, and folds

Neatly rolled up in a cell nucleus of only a hundredth of a millimetre in size, our genome consists of approximately two metres of DNA spread over 46 chromosomes. Three Oncode Investigators explain why they are fascinated by the spatial organization of this tiny ball of thread.

Lindavan den Berg

Geert Kops appointed as Scientific Director

Starting June 2018, professor Geert Kops will be Chief Scientific Officer of Oncode. In that role he is responsible for the overall research strategy and its proper execution.

AlexanderDuyndam

H.M. Queen Máxima officially launches Oncode Institute

With so much excellent cancer research already being done in the Netherlands, what value can a new organization add? That question was answered today in the presence of Her Majesty Queen Máxima, who officially opened Oncode Institute with an elegant gesture.

DesireeHoving

An open letter to patients

On the occasion of the launch of Oncode Institute, we, the institute’s founding scientists, wish to say a few words to you.

RenéBernards

The benefits of unrestricted grants

What if researchers were given money along with the freedom to work as they wished, without the red tape?

Hidde Boersma

Successful partnerships

What do haploid cells, the common cold and certain congenital illnesses have in common? Each one is the focus of a small biotech company started by fundamental researcher Thijn Brummelkamp.

Hidde Boersma